跳至主要内容
临床试验/NCT05807672
NCT05807672招募中不适用

MARF-E- Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2022年4月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
Association between T1-, T2- and diffusion-mappings and risk group classification

研究概览

简要总结

In this context, the aim of this study is to investigate the role of MRF in endometrial cancer. Several applications are possible. Firstly, T1-, T2- and DWI-mappings can be associated to molecular risk group classification, in order to stratify patients' risk without recurring to surgery. MRF parameters can be also correlated to prognosis, both in terms of disease-free survival (DFS) and overall survival (OS).

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with biopsy-proven endometrial cancer;
  • Women aged > 18 years old;
  • Signed Informed consent.

排除标准

  • Previous history of neoplasm;
  • Concurrent malignancies at other sites.

结局指标

主要结局

Association between T1-, T2- and diffusion-mappings and risk group classification

时间窗: 3 months

次要结局

  • Correlation between T1-, T2- and diffusion mappings and DFS and OS(3 years)
  • Diagnostic accuracy of T1-,T2- and diffusion-mappings deriving from MRF in myometrial invasion detection(3 months)
  • Evaluation of Radiomic and Radiogenomic models to predict recurrence in early stage EC and to predict DFS and OS(3 years)
  • Diagnostic accuracy of T1-,T2- and diffusion-mappings and pathological nodal involvement(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验